Viral Immunology, Vaccines, and Antivirals
A section of Viruses (ISSN 1999-4915).
Section Information
- acquired resistance and evolution
- regulatory/societal/legislation aspects
- immune system stimulation
- limitations of vaccines
- new developments and the future
- natural antivirals and their uses
- viral infections
- differences between antivirals and antibiotics in health care
- antiviral use in children
- immunology/animal models
- adverse effects
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- STING-Mediated Antiviral Activity and Viral Evasion (Deadline: 30 November 2023)
- Pharmacology of Antivirals Targeting Metabolism and Immunity (Deadline: 30 November 2023)
- Recent Advances in the Fight against Respiratory Viruses (Deadline: 30 November 2023)
- Advances and Novel Concepts in Herpesvirus Vaccines (Deadline: 30 November 2023)
- Viral Entry Inhibitors 2023 (Deadline: 30 November 2023)
- Viral Proteases: Modulation of Immune Responses and Antiviral Therapies (Deadline: 30 November 2023)
- Vaccines and Treatments for Viral Hemorrhagic Fevers (Deadline: 10 December 2023)
- Efficacy and Safety of Antiviral Therapy 2nd Edition (Deadline: 15 December 2023)
- Viral Infections and Immune Dysregulation 2023 (Deadline: 15 December 2023)
- Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection (Deadline: 15 December 2023)
- Vaccines against Enveloped RNA Viruses (Deadline: 15 December 2023)
- SARS-CoV-2: Vaccine Design and Host Immunity (Deadline: 15 December 2023)
- Novel and Repurposed Antiviral Agents (Deadline: 16 December 2023)
- Antibody Response to Dengue, Zika and Other Flaviviruses (Deadline: 20 December 2023)
- Innate and Adaptive Immunity to Cutaneous Virus Infection (Deadline: 30 December 2023)
- Virus-Like Particle Vaccines 2023 (Deadline: 30 December 2023)
- Enzymes as Antiviral Targets (Deadline: 31 December 2023)
- Viruses and Virus-Like Particles as Nanoplatforms for Vaccines, Diagnostic and Therapeutic Nanomedicine (Deadline: 31 December 2023)
- Computational Drug Discovery for Viral Infections (Deadline: 31 December 2023)
- Broadly Protective Anti-viral Vaccines (Deadline: 31 December 2023)
- Antivirals against Arboviruses (Deadline: 31 December 2023)
- Universal Influenza Vaccines for Humans and Animals (Deadline: 31 December 2023)
- Current ART, Virologic Failure and Implications for HIV Drug Resistance (Deadline: 6 January 2024)
- Recent Advances in Anti-HCV, Anti-HBV and Anti-flavivirus Agents (Deadline: 15 January 2024)
- Advances in Antiviral Agents against SARS-CoV-2 and Its Variants 2nd Edition (Deadline: 17 January 2024)
- RNA Viruses and Antibody Response 2nd Edition (Deadline: 31 January 2024)
- Innate Sensing and Restriction of Retroviruses (Deadline: 31 January 2024)
- Roles of Macrophages in Viral Infections (Deadline: 31 January 2024)
- Recent Advances in Antiviral Natural Products 2023 (Deadline: 31 January 2024)
- Control of Viral Epidemics through Vaccination (Deadline: 31 January 2024)
- New Advances in Arbovirus Vaccines (Deadline: 29 February 2024)
- Biologics for Emerging and Reemerging Viral Infections (Deadline: 29 February 2024)
- Antiviral Peptide (Deadline: 1 March 2024)
- Regulation of the Virus Lifecycle by Cellular RNA-Binding Proteins (Deadline: 1 March 2024)
- Integrase Inhibitors 2023 (Deadline: 15 March 2024)
- Host Cell-Virus Interaction 3rd Edition (Deadline: 15 March 2024)
- The Diverse Regulation of Transcription in Endogenous Retroviruses (Deadline: 28 March 2024)
- Unraveling the Pathogenesis of Persistent Virus Infection (Deadline: 31 March 2024)
- Novel Antiviral Targets against Emerging Viruses (Deadline: 31 March 2024)
- T Cells in Viral Infections Volume 2 (Deadline: 31 March 2024)
- Viral Strategies to Regulate Host Immunity or Signal Pathways (Deadline: 31 March 2024)
- Interferon-Induced Transmembrane Proteins at the Intersection of Virus Infection and Immunity (Deadline: 31 March 2024)
- Innate Immunity to Virus Infection 2nd Edition (Deadline: 31 March 2024)
- HIV-1 Infection and Immunometabolism: Relevance to HIV Pathogenesis and Persistence 2.0 (Deadline: 31 March 2024)
- Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation 2nd Edition (Deadline: 31 March 2024)
- Efficacy, Safety, and Immunogenicity of Vaccines against Viruses: From Network Medicine to Clinical Experimentation 2nd Edition (Deadline: 20 April 2024)
- Chronic Infection by Oncogenic Viruses (Deadline: 30 April 2024)
- Broad-Spectrum Antivirals and Interaction with Viruses (Deadline: 30 April 2024)
- Natural Killer Cell in Viral Infection (Deadline: 30 April 2024)
- CRISPR/Cas in Viral Research 2024 (Deadline: 30 April 2024)
- Rabies Virus: Treatment and Prevention (Deadline: 30 April 2024)
- Antiviral Immune Responses of Bat (Deadline: 30 April 2024)
- Viral Sepsis: Pathogenesis, Diagnostics and Therapeutics (Deadline: 1 May 2024)
- Animal Coronaviruses: Infection, Prevention, and Antivirals (Deadline: 20 May 2024)
- Mucosal Immunity to Respiratory Viruses (Deadline: 31 May 2024)
- Structure-Guided Antiviral Discovery: From Target Validation to Drug Design to Candidate Selection (Deadline: 31 May 2024)
- Advanced Strategies against SARS-CoV-2 Variants and Future Emerging Virus Outbreaks (Deadline: 31 May 2024)
- TRIM Proteins in Antiviral Immunity and Virus Pathogenesis (Deadline: 30 June 2024)
- Immune Responses to Papillomavirus Infections (Deadline: 30 June 2024)
- Epigenetic and Transcriptional Regulation of DNA Virus Infections (Deadline: 30 June 2024)
- B Cell-Mediated Immunity to Viruses (Deadline: 30 June 2024)
- Next Generation Sequencing for HIV Drug Resistance Testing 2nd Edition (Deadline: 30 June 2024)
- Antiviral Resistance Mutations (Deadline: 30 June 2024)
- Innate and Adaptive Immune Responses to Arbovirus Infections (Deadline: 31 July 2024)
- Protein–Protein Interactions in the Discovery of Antiviral Drugs (Deadline: 31 July 2024)
- Pathogenesis of Arbovirus Infections (Deadline: 31 July 2024)
- Elimination of Viral Hepatitis: Improving Diagnosis, Treatment and Surveillance 2.0 (Deadline: 16 August 2024)
- Mechanisms of Herpesvirus Resistance (Deadline: 31 August 2024)
- Viruses, MicroRNAs and Host Interactions (Deadline: 31 August 2024)
- Immunity to Enteric Viruses (Deadline: 30 September 2024)